Same company, two genuinely different procedures. BodyTite works under the skin: a cannula is inserted through a small entry point and radiofrequency runs between that internal tube and an electrode on the surface. Morpheus8 works through the skin: an array of insulated needles is pressed in, and heat is released from the last half-millimetre of each needle.
One is done in an operating context, the other in a treatment room. BodyTite is positioned by its manufacturer for large body areas — abdomen, flanks, arms, thighs — and used alongside liposuction. Published series of this technique describe it under local anaesthesia. Morpheus8 is an in-office treatment where topical numbing cream is standard and usually included in the price.
Neither clearance names a cosmetic use. BodyTite is not the name on any FDA clearance — it is a handpiece under InMode's general "InMode RF System" clearances, worded as electrocoagulation and hemostasis, which is surgical language for sealing tissue and stopping bleeding. Morpheus8's own clearances read the same way: electrocoagulation and hemostasis in December 2019 (K192695), then coagulation or contraction of soft tissue in July 2023 (K231790). Fat reduction, body contouring, cellulite, stretch marks and skin tightening appear in neither.
InMode does hold real cosmetic claims — on different machines, and this distinction matters. The BodyFX, WMbody and EmBodyFX applicators (EmBodyFX is sold as Evolve Trim) are cleared for "temporary reduction in the appearance of cellulite" - WMbody under K131362 (2013), EmBodyFX under K183450 (2019). The Evolve Transform applicator is cleared for "non-invasive lipolysis (breakdown of fat) of the abdomen" and "reduction in circumference of the abdomen" (K231495, 2023) — the abdomen and nowhere else. So a clinic saying "InMode is FDA cleared for fat and cellulite" is describing other applicators, not these two.
Temperature and tissue resistance are monitored and energy adjusts automatically. In the manufacturer-aligned technical account the internal cut-off is 69 to 70 °C and the skin-surface cut-off 38 to 40 °C.
The pins are coated with insulation except the distal 0.5 mm, so the energy leaves the needle at its tip rather than at the skin surface.
No cannula length or gauge is published.
The highest depth in any FDA summary is 7.0 mm. The widely quoted "8 mm" is a 2020 marketing figure — 7 mm of needle plus 1 mm of thermal profile — and depth is not something the FDA clears in the first place.
Liposuction, lipolysis, fat reduction, body contouring and skin tightening appear in none of the clearances covering these handpieces.
Above 62 mJ per pin, Morpheus8 is limited on-label to skin types I to IV.
No published trial gives a recovery figure, so none is quoted. Structurally it is a procedure with an entry point, an anaesthetic and, usually, liposuction alongside it.
A separate study measured skin barrier function and found it disturbed for the first few days and back to baseline by day seven.
Neither device has a randomised controlled trial. For BodyTite and its siblings, PubMed returns about 32 records, mostly case series and technique papers, several written by paid InMode consultants. The 2010 safety and feasibility study treated 23 patients, averaged 2,404 mL of aspirate and reported no severe complications — but the skin tightening was judged by the operating surgeon, unblinded, and the authors asked for a larger sample.
For Morpheus8, a PubMed search returns 16 records and no randomised trial. The broader RF microneedling evidence base is real, and mostly generated on other machines — Lutronic Genius and Infini, Jeisys, Pollogen, Lumenis and several unnamed devices. Anyone shown "the studies" for Morpheus8 is usually being shown research done with somebody else's equipment. The longest properly measured follow-up in that literature is six months.
The one study that put both devices side by side was in animals. A 24-rat histopathology study compared BodyTite alone, Morpheus8 alone, both together and an untreated control, and reported collagen scores of 1.5, 2 and 3 for the three treated groups. That is a rat, at one timepoint, scored on a biopsy. It does not tell you what either device does to a person, and it is not a reason to buy the combination.
Fat loss is the third most frequently reported complication category in the FDA's post-market database for RF microneedling — 26 of 224 reported events between 2013 and 2025. That is a share of reports, not a risk to you. The database is voluntary, has no denominator and cannot be turned into a per-patient chance of anything.
Against it: a 2024 split-face study measured the submental fat layer by ultrasound after microneedle radiofrequency and found it unchanged. The paper's own title says "without lipolysis". So dermal-depth needle radiofrequency at studied settings did not thin the fat layer in a controlled setting.
The reason this cuts both ways here is that BodyTite deliberately works in the fat layer, and Morpheus8's deeper tips reach the subdermal plane. A device class capable of affecting fat on purpose is capable of doing it accidentally. There is no published incidence figure, no case series describing it and no established treatment for it.
If you get cold sores, say so when you book — not on the day. Antiviral medicine is started in advance, so it has to be prescribed before the appointment. There is no published data on cold-sore reactivation after these treatments specifically; the precaution is carried over from laser resurfacing, where reactivation is well documented and prophylaxis is standard.
Also disclose a pacemaker or an implantable defibrillator, and any metal implant near the treatment area. These are labelled contraindications for radiofrequency devices generally. They are precautionary rather than tested — no published study has treated patients with cardiac implants — so the people to advise you are your cardiology team, not the clinic's front desk.
Say too if you have an active skin infection in the area, a history of raised or thickened scarring, or any current or past skin cancer where you are being treated.
These are signs of an infection that is spreading, and they need urgent care rather than a wait-and-see appointment.